Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Differences in the amount of fetal hemoglobin (HbF) that persists into adulthood affect the severity of sickle cell disease and the β-thalassemia syndromes. Genetic association studies have identified sequence variants in the gene BCL11A that influence HbF levels. Here, we examine BCL11A as a potential regulator of HbF expression. The high-HbF BCL11A genotype is associated with reduced BCL11A expression. Moreover, abundant expression of full-length forms of BCL11A is developmentally restricted to adult erythroid cells. Down-regulation of BCL11A expression in primary adult erythroid cells leads to robust HbF expression. Consistent with a direct role of BCL11A in globin gene regulation, we find that BCL11A occupies several discrete sites in the β-globin gene cluster. BCL11A emerges as a therapeutic target for reactivation of HbF in β-hemoglobin disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The retention of both HBG genes, each with slightly different promoter sequences, also contributes to nuanced regulatory control and may influence HbF levels in adults, a feature of clinical relevance in disorders like β-thalassemia and sickle cell disease [97].”
From Origin and Evolution of Genes in Eukaryotes: Mechanisms, Dynamics, and Functional Implications (2025) · cites this paper as [97]
In the citing paper
“Reducing bcl11a expression in transgenic sickle mice derepressed g-globin genes.17,18”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [17]
In the citing paper
“current treatments aim to induce the expression of non-mutated fetal hemoglobin (HbF), which is functional but transcriptionally repressed post-birth (Sankaran et al. 2008).”
From From serendipity to strategy: molecular glue degraders in cancer therapeutics (2025) · cites this paper as Sankaran et al. 2008
In the citing paper
“Further molecular studies revealed that BCL11A interacts with several erythroid regulators including GATA1, FOG1, and SOX6, and with the nucleosome remodeling and deacetylase complex (NuRD) (4, 6).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [4]
In the citing paper
“We identi fi ed numerous peptides of BCL11A and nearly all previously established interacting proteins, including FOG1, the entire NuRD complex, and the nuclear matrix protein MATRIN-3 (4).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [4]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Self-citationA Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma
Moffatt, M. F., Kabesch, M., Liang, L., Dixon, A. L., Strachan, D., Heath, S., Depner, M., von Berg, A., Bufe, A., Rietschel, E., et al. (2007) · Nature · doi:10.1038/nature06014 · Cited by 1,604
A HapMap harvest of insights into the genetics of common disease
Manolio, T. A., Brooks, L. D., & Collins, F. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34772 · Cited by 889
Tsai, S.-F., Martin, D. I. K., Zon, L. I., D'Andrea, A. D., Wong, G. G., & Orkin, S. H. (1989) · Nature · doi:10.1038/339446a0 · Cited by 885
Self-citationTsang, A. P., Visvader, J. E., Turner, C. A., Fujiwara, Y., Yu, C., Weiss, M. J., Crossley, M., & Orkin, S. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80318-9 · Cited by 712
Self-citationUda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V. G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711566105 · Cited by 672
Self-citationLettre, G., Sankaran, V. G., Bezerra, M. A. C., Araújo, A. S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F. F., Hirschhorn, J. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804799105 · Cited by 561
Self-citationA QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., et al. (2007) · Nature Genetics · doi:10.1038/ng2108 · Cited by 529
Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes
Göring, H. H. H., Curran, J. E., Johnson, M. P., Dyer, T. D., Charlesworth, J., Cole, S. A., Jowett, J. B. M., Abraham, L. J., Rainwater, D. L., Comuzzie, A. G., et al. (2007) · Nature Genetics · doi:10.1038/ng2119 · Cited by 504
Cited by
Items 501–600 of 1,001
Recent Approaches for Manipulating Globin Gene Expression in Treating Hemoglobinopathies
Mussolino, C., & Strouboulis, J. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.618111 · Cited by 19
Role of Nuclear Receptors in Controlling Erythropoiesis
Pastori, V., Pozzi, S., Łabędź, A., Ahmed, S., & Ronchi, A. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052800 · Cited by 18
Emergent treatments for β-thalassemia and orphan drug legislations
Costa, E., Cappellini, M. D., Rivella, S., Chilin, A., Alessi, E., Riccaboni, M., Leufkens, H. G. M., & Luzzatto, L. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103342 · Cited by 18
Gene Therapy for Hemoglobinopathies
Lidonnici, M. R., Scaramuzza, S., & Ferrari, G. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.138 · Cited by 18
Pecoraro, A., Rigano, P., Troia, A., Calzolari, R., Scazzone, C., Maggio, A., Steinberg, M. H., & Marzo, R. D. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12204 · Cited by 18
Induction of human fetal hemoglobin expression by adenosine-2’,3’-dialdehyde
He, Y., Rank, G., Zhang, M., Ju, J., Liu, R., Xu, Z., Brown, F. C., Cerruti, L., Ma, C., Tan, R. X., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-14 · Cited by 18
A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
Porter, S. N., Levine, R. M., & Pruett‐Miller, S. M. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180022 · Cited by 18
Schaeffer, E. K., West, R. J., Conine, S. J., & Lowrey, C. H. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.10.007 · Cited by 18
Hemoglobin F level in different hemoglobin variants
Olufemi, A. E., Sola, O. B., Bamisaye, O. E., Ajani, R. A., Mewoyeka, O. O., & Olubunmi, H. R. (2011) · The Korean Journal of Hematology · doi:10.5045/kjh.2011.46.2.118 · Cited by 18
Advances in hemoglobinopathy detection and identification
Troxler, H., Kleinert, P., Schmugge, M., & Speer, O. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-394384-2.00001-2 · Cited by 18
GWAS to Therapy by Genome Edits?
Hardison, R. C., & Blobel, G. A. (2013) · Science · doi:10.1126/science.1245813 · Cited by 15
Downes, D. J., Schweßinger, R., Hill, S., Nußbaum, L., Scott, C., Gosden, M. E., Hirschfeld, P. P., Telenius, J. M., Eijsbouts, C. Q., McGowan, S. J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/813618 · Cited by 18
Implications of hematopoietic stem cells heterogeneity for gene therapies
Epah, J., & Schäfer, R. (2021) · Gene Therapy · doi:10.1038/s41434-021-00229-x · Cited by 18
Origin and Evolution of Genes in Eukaryotes: Mechanisms, Dynamics, and Functional Implications
Saccone, S., Brancato, D., Bruno, F., Coniglio, E., Sturiale, V., & Federico, C. (2025) · Genes · doi:10.3390/genes16060702 · Cited by 17
Allogenic Cord Blood Transfusion in Preterm Infants
Teofili, L., Papacci, P., Giannantonio, C., Bianchi, M., Valentini, C. G., & Vento, G. (2023) · Clinics in Perinatology · doi:10.1016/j.clp.2023.07.005 · Cited by 17
Estimation of the difference in HbF expression due to loss of the 5' -globin BCL11A binding region
Ghedira, E. S., Lecerf, L., Faubert, E., Costes, B., Moradkhani, K., Bachir, D., Galactéros, F., & Pissard, S. (2012) · Haematologica · doi:10.3324/haematol.2012.061994 · Cited by 17
Recent advances in globin research using genome‐wide association studies and gene editing
Orkin, S. H. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13001 · Cited by 17
Self-citationVinjamur, D. S., Alhashem, Y. N., Mohamad, S., Amin, P. H., Williams, D. C., & Lloyd, J. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146802 · Cited by 17
Zhou, J., Yang, Y., Zhang, D., Zhou, L. F., Tao, L., & Lu, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171116 · Cited by 17
Uchida, N., Ferrara, F., Drysdale, C. M., Yapundich, M., Gamer, J., Nassehi, T., DiNicola, J., Shibata, Y., Wielgosz, M. M., Kim, Y., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb0411 · Cited by 17
Predictive SNPs for β0-thalassemia/HbE disease severity
Munkongdee, T., Tongsima, S., Ngamphiw, C., Wangkumhang, P., Peerapittayamongkol, C., Hashim, H., Fucharoen, S., & Svasti, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-89641-2 · Cited by 17
Epigenomic analysis of KLF1 haploinsufficiency in primary human erythroblasts
Heshusius, S., Grech, L., Gillemans, N., Brouwer, R. W. W., den Dekker, A. T., van IJcken, W. F. J., Nota, B., Felice, A. E., van Dijk, T. B., Lindern, M. V., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-04126-6 · Cited by 17
Ludwig, L. S., Cho, H., Wakabayashi, A., Eng, J. C., Ulirsch, J. C., Fleming, M. D., Lodish, H. F., & Sankaran, V. G. (2015) · American Journal of Hematology · doi:10.1002/ajh.23952 · Cited by 17
Self-citationBreveglieri, G., Bianchi, N., Cosenza, L. C., Gamberini, M. R., Chiavilli, F., Zuccato, C., Montagner, G., Borgatti, M., Lampronti, I., Finotti, A., et al. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0450-3 · Cited by 17
Izumikawa, K., Ishikawa, H., Simpson, R. J., & Takahashi, N. (2018) · RNA Biology · doi:10.1080/15476286.2018.1465795 · Cited by 17
DNA methylation patterns of β-globin cluster in β-thalassemia patients
Bao, X., Zuo, Y., Chen, D., & Zhao, C. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00987-2 · Cited by 17
The ncBAF Complex Regulates Transcription in AML Through H3K27ac Sensing by BRD9
Klein, D. C., Lardo, S. M., & Hainer, S. J. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0382 · Cited by 16
Treating genetic blood disorders in the era of CRISPR-mediated genome editing
Almotiri, A., Abogosh, A., Abdelfattah, A., Alowaisy, D., & Rodrigues, N. P. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.031 · Cited by 16
Fanis, P., Kousiappa, I., Phylactides, M., Kyrri, A. R., Hadjigavriel, M., Christou, S., Sitarou, M., & Kleanthous, M. (2019) · Human Mutation · doi:10.1002/humu.23817 · Cited by 16
Physiological and Aberrant γ-Globin Transcription During Development
Barbarani, G., Łabędź, A., Stucchi, S., Abbiati, A., & Ronchi, A. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.640060 · Cited by 17
Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency
Wessels, M. W., Cnossen, M. H., van Dijk, T. B., Gillemans, N., Schmidt, K. L. J., van Lom, K., Vinjamur, D. S., Coyne, S. M., Kurita, R., Nakamura, Y., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003753 · Cited by 16
Vickridge, E., Faraco, C. C. F., Samavarchi‐Tehrani, P., Ramdzan, Z. M., Djerir, B., Rahimian, H., Leduy, L., Maréchal, A., Gingras, A., & Nepveu, A. (2022) · NAR Cancer · doi:10.1093/narcan/zcac028 · Cited by 16
Banan, M., Bayat, H., Namdar‐Aligoodarzi, P., Azarkeivan, A., Kamali, K., Daneshmand, P., Zaker-Kandjani, B., & Najmabadi, H. (2013) · Hemoglobin · doi:10.3109/03630269.2013.805418 · Cited by 16
Al-Allawi, N. A. S., Qadir, S. M. A., Puehringer, H., Chui, D. H. K., Farrell, J. J., & Oberkanins, C. (2018) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12927 · Cited by 16
Hemoglobinopathies in the Fetal Position
Pasricha, S., & Drakesmith, H. (2018) · New England Journal of Medicine · doi:10.1056/nejmcibr1809628 · Cited by 16
Nicolau, M., Vargas, S., Silva, M., Coelho, A., Ferreira, E., Mendonça, J., Vieira, L., Kjöllerström, P., Maia, R., Silva, R., et al. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03783-y · Cited by 16
Gazouli, M., Katsantoni, E. Z., Kosteas, T., & Anagnou, N. P. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00019 · Cited by 16
Elucidation of the role of LMO2 in human erythroid cells
Inoue, A., Fujiwara, T., Okitsu, Y., Katsuoka, Y., Fukuhara, N., Onishi, Y., Ishizawa, K., & Harigae, H. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.09.003 · Cited by 15
Transcriptional Repressor BCL11A in Erythroid Cells
Zheng, G., & Orkin, S. H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_9 · Cited by 15
Self-citationFinotti, A., Gasparello, J., Breveglieri, G., Cosenza, L. C., Montagner, G., Bresciani, A., Altamura, S., Bianchi, N., Martini, E., Gallerani, E., et al. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.08.011 · Cited by 15
Transcriptional Repressors of Fetal Globin Genes as Novel Therapeutic Targets in Beta-Thalassemia
Martino, M. D., Sessa, R., Storino, M. R., Giuliano, M., Trombetti, S., Catapano, R., Bianco, A. L., Izzo, P., & Grosso, M. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90762 · Cited by 15
Current and future gene therapies for hemoglobinopathies
Brendel, C., & Williams, D. A. (2020) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000581 · Cited by 15
Red Blood Cells as Therapeutic Target to Treat Sickle Cell Disease
Bhatt, S., Argueta, D. A., Gupta, K., & Kundu, S. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0348 · Cited by 15
A Dual Reporter Mouse Model of the Human β-Globin Locus: Applications and Limitations
Papadopoulos, P., Gutiérrez, L., van der Linden, R., Kong-a-San, J., Maas, A., Drabek, D., Patrinos, G. P., Philipsen, S., & Grosveld, F. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051272 · Cited by 15
Regulation of Gγ-Globin Gene by ATF2 and Its Associated Proteins through the cAMP-Response Element
Liu, L., Karmakar, S., Dhar, R., Mahajan, M. C., Choudhury, A., Weissman, S. M., & Pace, B. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078253 · Cited by 15
Long-range gene regulation and novel therapeutic applications
van den Heuvel, A., Stadhouders, R., Andrieu‐Soler, C., Grosveld, F. G., & Soler, É. (2015) · Blood · doi:10.1182/blood-2014-11-567925 · Cited by 15
The BCL11A-XL expression predicts relapse in squamous cell carcinoma and large cell carcinoma.
Zhang, N., Jiang, B., Zhang, X., Xie, Z., Su, J., Zhang, Q., Han, J.-F., Tu, H., & Wu, Y.-L. L. C. (2015) · PubMed · doi:10.3978/j.issn.2072-1439.2015.09.39 · Cited by 15
Epigenetic interplay at the β-globin locus
Lee, W. S., McColl, B., Maksimovic, J., & Vadolas, J. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.01.014 · Cited by 15
Ali, H., Iftikhar, F., Shafi, S., Siddiqui, H. L., Khan, I. A., Choudhary, M. I., & Musharraf, S. G. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.05.027 · Cited by 15
Okam, M. M., & Ebert, B. L. (2012) · Expert Review of Hematology · doi:10.1586/ehm.12.20 · Cited by 15
Hojjati, M. T., Azarkeivan, A., Pourfathollah, A. A., & Amirizadeh, N. (2017) · Hemoglobin · doi:10.1080/03630269.2017.1290651 · Cited by 15
Molecular and Cellular Basis of Hemoglobin Switching
Stamatoyannopoulos, G., Navas, P. A., & Li, Q. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.009 · Cited by 15
Varricchio, L., Fabucci, M. E., Alfani, E., Godbold, J., & Migliaccio, A. R. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02483.x · Cited by 15
Upadhye, D. S., Jain, D., Trivedi, Y. L., Nadkarni, A. H., Ghosh, K., & Colah, R. B. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2675-1 · Cited by 14
Adelvand, P., Hamid, M., & Sardari, S. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2018.1406795 · Cited by 14
Rivers, A. E., Jagadeeswaran, R., & Lavelle, D. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00440.2017 · Cited by 14
Natural and Experimental Rewiring of Gene Regulatory Regions
Downes, D. J., & Hughes, J. R. (2022) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-112921-010715 · Cited by 14
Ikuta, T., Kurayanagi, Y., Odo, N., & Liu, S. M. (2013) · Journal of Blood Medicine · doi:10.2147/jbm.s54671 · Cited by 14
Genetic Factors Modifying Sickle Cell Disease Severity
Gardner, K., & Thein, S. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_15 · Cited by 14
Modelling human haemoglobin switching
Diepstraten, S. T., & Hart, A. H. (2018) · Blood Reviews · doi:10.1016/j.blre.2018.06.001 · Cited by 14
Hit and Run Transcriptional Repressors Are Difficult to Catch in the Act
Shah, M., Funnell, A. P. W., Quinlan, K. G. R., & Crossley, M. (2019) · BioEssays · doi:10.1002/bies.201900041 · Cited by 13
Prime editing: A potential treatment option for β‐thalassemia
Arif, T., Farooq, A., Ahmad, F. J., Akhtar, M., & Choudhery, M. S. (2022) · Cell Biology International · doi:10.1002/cbin.11972 · Cited by 14
Hemoglobinopathies and Thalassemias
Peslak, S. A., & Sayani, F. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-812534-2.00009-6 · Cited by 14
Cui, J., Azimi, M., Baysdorfer, C., Vichinsky, E. P., & Hoppe, C. C. (2013) · Hemoglobin · doi:10.3109/03630269.2013.782461 · Cited by 14
Treatment by CRISPR-Cas9 Gene Editing — A Proof of Principle
Malech, H. L. (2021) · New England Journal of Medicine · doi:10.1056/nejme2034624 · Cited by 14
Rajendiran, V., Devaraju, N., Haddad, M., Ravi, N. S., Panigrahi, L., Paul, J., Gopalakrishnan, C., Wyman, S. K., Ariudainambi, K., Mahalingam, G., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.01.023 · Cited by 13
Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulation
Agarwal, G., Antoszewski, M., Xie, X., Pershad, Y., Arora, U. P., Poon, C.-L., Lyu, P., Lee, A. J., Guo, C., Ye, T., et al. (2026) · Science · doi:10.1126/science.adx4174 · Cited by 13
Self-citationUtilizing Whole-Exome Sequencing to Characterize the Phenotypic Variability of Sickle Cell Disease
Alsultan, A. S., AlSuliman, A. M., Aleem, A., AlGahtani, F. H., & Alfadhel, M. (2018) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2018.0058 · Cited by 13
Bagla, S., Regling, K., Wakeling, E. N., Gadgeel, M., Buck, S. A., Zaidi, A. U., Flore, L. A., Chicka, M. C., Schiffer, C. A., Chitlur, M., et al. (2020) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2020.1814463 · Cited by 13
Heterogeneity of fetal hemoglobin production in adult red blood cells
Khandros, E., & Blobel, G. A. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000640 · Cited by 13
Ali, H., Khan, F., & Musharraf, S. G. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114612 · Cited by 13
Wongborisuth, C., Chumchuen, S., Sripichai, O., Anurathapan, U., Sathirapongsasuti, N., Songdej, D., Tangprasittipap, A., & Hongeng, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-08920-8 · Cited by 13
C2H2 Zinc Finger Transcription Factors Associated with Hemoglobinopathies
Zhang, X., Xia, F., Zhang, X., Blumenthal, R., & Cheng, X. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168343 · Cited by 13
Fulton, J., Mazumder, B., Whitchurch, J. B., Monteiro, C. J., Collins, H. M., Chan, C. M., Clemente-Olivo, M. P., Hernández-Quiles, M., Stewart, E. A., Amoaku, W. M. K., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.98 · Cited by 13
Novel and innovative approaches for treatment of β-thalassemia
Soni, S. (2017) · Pediatric Hematology Oncology Journal · doi:10.1016/j.phoj.2017.11.153 · Cited by 13
Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias
Foong, W. C., Ho, J. J., Loh, C. K., & Viprakasit, V. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011579 · Cited by 13
Genome-Wide Assessment of Pleiotropy Across >1000 Traits from Global BiobanksPreprint
Levin, M. G., Koyama, S., Woerner, J., Zhang, D. Y., Rodriguez, A., Nandi, T., Truong, B. M. T., Abramowitz, S. A., Gupta, H., Kamineni, H., et al. (2025) · medRxiv · doi:10.1101/2025.04.18.25326074 · Cited by 13
Yang, D. C., Ma, Z.-F., Lin, W., Yang, J., Tian, C., Wei, H., Jiang, Y., & He, F. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2012.12.014 · Cited by 12
Silencing of BCL11A by disrupting enhancer-dependent epigenetic insulation
Wang, K., Wang, J., Feng, R., Dudnyk, K., Kim, Y. J., Lim, J. Y. S., Lee, M., Zhang, Y., Gao, X., Cheng, Y., et al. (2025) · Blood · doi:10.1182/blood.2025030211 · Cited by 12
Self-citationChakraborty, C., Bhattacharya, M., Das, A., Agoramoorthy, G., & Lee, S.-S. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102859 · Cited by 12
Epigenetic and genetic mechanisms in red cell biology
Hewitt, K. J., Sanalkumar, R., Johnson, K. D., Keleş, S., & Bresnick, E. H. (2014) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000034 · Cited by 12
Ali, H., Khan, F., & Musharraf, S. G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112058 · Cited by 12
Ibañez, V., Vaitkus, K., Zhang, X., Jagadeeswaran, R., Rivers, A. E., Saunthararajah, Y., Molokie, R. E., & Lavelle, D. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009558 · Cited by 12
Catapano, R., Sessa, R., Trombetti, S., Cesaro, E., Russo, F., Izzo, P., Makis, A. C., & Grosso, M. (2023) · Biology · doi:10.3390/biology12040510 · Cited by 12
Huo, Y., McConnell, S. C., Liu, S., Zhang, T., Yang, R., Ren, J., & Ryan, T. M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05547.x · Cited by 12
Fornari, T. A., Lanaro, C., de Albuquerque, D. M., Ferreira, R., & Costa, F. F. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216668052 · Cited by 12
TCF4 promotes erythroid development
Hout, F. E. M. I. ’., van Duren, J., Monteferrario, D., Brinkhuis, E., Mariani, N., Westers, T. M., Chitu, D. A., Nikoloski, G., van de Loosdrecht, A. A., van der Reijden, B. A., et al. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.10.002 · Cited by 12
Junker, L. H., Li, Y., Zhu, X., Koti, S., Cerbone, R. E., Hendrick, C. L., Sangerman, J., Perrine, S. P., & Pace, B. S. (2021) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2021.102626 · Cited by 12
Li, Y., Ding, L., Yang, C., Kang, B., Liu, L., Story, M. D., & Pace, B. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107133 · Cited by 12
Cico, A., Andrieu‐Soler, C., & Soler, É. (2016) · FEBS Letters · doi:10.1002/1873-3468.12424 · Cited by 12
Influences of Genetic Variation on Fetal Hemoglobin
He, Y., Lin, W., & Luo, J. (2011) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2011.616573 · Cited by 12
Resolving the chromatin impact of mosaic variants with targeted Fiber-seq
Bohaczuk, S. C., Amador, Z. J., Li, C. L., Mallory, B. J., Swanson, E. G., Ranchalis, J., Vollger, M. R., Munson, K. M., Walsh, T., Hamm, M. O., et al. (2024) · Genome Research · doi:10.1101/gr.279747.124 · Cited by 12
Ex vivo modification of hematopoietic stem and progenitor cells for gene therapy
Williams, D. A., Kohn, D. B., & Thrasher, A. J. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.058 · Cited by 11
Horton, J. R., Yu, M., Zhou, J., Tran, M. L., Anakal, R. R., Lu, Y., Blumenthal, R., Zhang, X., Huang, Y., Zhang, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58998-7 · Cited by 11
Khamphikham, P., Jearawiriyapaisarn, N., Tangprasittipap, A., & Hongeng, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10539 · Cited by 11
Human genetics implicates a BACH2–NRF2 axis in fetal haemoglobin activation
Guo, C., Arora, U. P., Cheng, X., Xu, W., Cato, L. D., Li, R., Lu, H. Y., Lee, A., Yu, F., Agarwal, G., et al. (2026) · Nature · doi:10.1038/s41586-026-11113-2 · Cited by 11
Self-citationEmerging cellular and gene therapies for congenital anemias
Ludwig, L. S., Khajuria, R. K., & Sankaran, V. G. (2016) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31529 · Cited by 11
Self-citationVasseur, C., Domingues‐Hamdi, E., Dudal, K. L., Corvoisier, P. L., Barau, C., Ghaleh, B., Rialland, A., Pissard, S., Galactéros, F., & Baudin‐Creuza, V. (2017) · British Journal of Haematology · doi:10.1111/bjh.14800 · Cited by 11
Tangprasittipap, A., Kaewprommal, P., Sripichai, O., Sathirapongsasuti, N., Satirapod, C., Shaw, P. J., Piriyapongsa, J., & Hongeng, S. (2018) · PeerJ · doi:10.7717/peerj.5527 · Cited by 11
Engineering Globin Gene Expression
Davis, R., Gurumurthy, A., Hossain, M. A., Gunn, E. M., & Bungert, J. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.12.004 · Cited by 11
Metadata
- Authors
- Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H.
- Affiliations
- Broad Institute (US)
- Division of Hematology/Oncology, Children's Hospital Boston, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.
- Corresponding author
- Orkin, Stuart H.
- ORCID
- Venue
- Science
- Published
- 2008-12-19
- Volume
- 322
- Issue
- 5909
- Pages
- 1839-1842
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1968165696
- Semantic Scholar
- a52e99500fd26811a2ae248d6dce95e3152b5bb7
- Cited by
- 919
- References
- 27
- Citations by year
- 2026: 59 · 2025: 46 · 2024: 55 · 2023: 52 · 2022: 47 · 2021: 73 · 2020: 70 · 2019: 31 · 2018: 50 · 2017: 59 · 2016: 63 · 2015: 46 · 2014: 45 · 2013: 53 · 2012: 49
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (HL32262-26, P01HL032262, R01HL032259, HL32259-27)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- fetal hemoglobin, BCL11A, globin gene regulation, beta-globin gene cluster, sickle cell disease, beta-thalassemia, erythroid cells, therapeutic target
- MeSH terms
- Animals, Carrier Proteins, Cells, Cultured, Erythroblasts, Erythropoiesis, Fetal Hemoglobin, Gene Expression Regulation, Multigene Family, Hemoglobinopathies, Histone Deacetylases, Humans, Nuclear Proteins, Repressor Proteins, Transcription Factors, Transcription, Genetic, Down-Regulation, Erythroid Precursor Cells, K562 Cells, Protein Isoforms, Polymorphism, Single Nucleotide, RNA Interference, Erythroid Cells, Cell Line, Tumor, GATA1 Transcription Factor, Mice, beta-Globins, gamma-Globins, Mi-2 Nucleosome Remodeling and Deacetylase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.